Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33754642

Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Jun 24
First author
Rogers KA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Jun 24;137(25):3461-3462. doi: 10.1182/blood.2021011574.
    note
    Source null
    related pmid
    34165548
    relationship
    Comment in

Authors and identifiers

  1. name
    Rogers KA
    type
    Author
  2. name
    Andritsos LA
    type
    Author
  3. name
    Wei L
    type
    Author
  4. name
    McLaughlin EM
    type
    Author
  5. name
    Ruppert AS
    type
    Author
  6. name
    Anghelina M
    type
    Author
  7. name
    Blachly JS
    type
    Author
  8. name
    Call T
    type
    Author
  9. name
    Chihara D
    type
    Author
  10. name
    Dauki A
    type
    Author
  11. name
    Guo L
    type
    Author
  12. name
    Ivy SP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rogers KA
    type
    Author
  2. name
    Andritsos LA
    type
    Author
  3. name
    Wei L
    type
    Author
  4. name
    McLaughlin EM
    type
    Author
  5. name
    Ruppert AS
    type
    Author
  6. name
    Anghelina M
    type
    Author
  7. name
    Blachly JS
    type
    Author
  8. name
    Call T
    type
    Author
  9. name
    Chihara D
    type
    Author
  10. name
    Dauki A
    type
    Author
  11. name
    Guo L
    type
    Author
  12. name
    Ivy SP
    type
    Author
bibliography ids
  1. nci-bib-fe44780984c82befe4074807
book metadata
content sha256
b95003b001e42375596b0c960777f461c673cd405707fcc9c6f41473281fae64
document type
citation
dois
  1. 10.1182/blood.2020009688
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33754642
immutable id
pubmed:33754642@b95003b001e42375596b0c960777f461c673cd405707fcc9c6f41473281fae64
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
25
name
Blood
nlm unique id
7603509
pages
3473-3483
volume
137
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Jun 24;137(25):3461-3462. doi: 10.1182/blood.2021011574.
    note
    Source null
    related pmid
    34165548
    relationship
    Comment in
outcomes validated
false
pmid
33754642
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
ebe37964b05f09624ab15f1d024e14e3fb67300466e334be4852386b03b6f0af
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jun 24
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33754642/
title
Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.

Preserved source evidence · Not medical advice